高质量CLTI诊疗需在旁路手术和腔内治疗均达到优于平均水平
该研究基于BEST-CLI试验数据,采用累积概率质量指标(EO和WAA)评估146个中心对1440例CLTI患者的整体表现。2年MALE/死亡在中心四分位间差异显著(Q1 58% vs Q4 30%,P<.001)。顶尖中心中84%在旁路和腔内治疗均优于平均水平,提示最佳CLTI诊疗需双模式精通。
要点
- 2年MALE/死亡在中心间差异约30%(Q1 58% vs Q4 30%)。
- 顶尖中心84%在旁路和腔内治疗均优于平均水平。
- 仅擅长单一模式的中心较少成为顶尖中心。
核心结论
- 最佳CLTI诊疗要求旁路手术和腔内治疗均达到优于平均水平的中心表现。
研究设计与样本
- 基于BEST-CLI试验数据,纳入1440例患者(占随机患者的79%),覆盖146个中心。
- 采用累积概率质量指标EO和WAA,以MALE/死亡为复合终点,经Cox模型风险调整后按WAA四分位分组。
主要发现
- 2年未调整MALE/死亡随WAA四分位升高而降低:Q1 58%、Q2 43%、Q3 33%、Q4 30%(P < .001)。
- 中心按WAA分布:双模式均优于平均27%,仅旁路优于平均27%,仅腔内优于平均21%,双模式均低于平均25%。
- 顶尖中心(Q4)中84%双模式均优于平均,而底端中心(Q1)中62%双模式均低于平均。
- 仅擅长单一模式的中心占顶尖中心的16%(仅旁路3%,仅腔内14%),占底端中心的38%(仅旁路27%,仅腔内11%)。
临床怎么用
- 评估CLTI中心质量时需同时考量旁路和腔内治疗的表现,而非仅关注单一模式。
- 可借鉴EO和WAA等累积概率指标,以更好区分中心层面的性能差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Best Endovascular vs Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (CLTI) (BEST-CLI) trial compared surgical bypass and endovascular treatment in patients with CLTI. Although center-level variation in vascular surgery outcomes is well-documented, its impact within BEST-CLI has not been explored. Moreover, traditional quality metrics often fail to adequately discriminate center-level performance. This study introduces cumulative, probability-based quality metrics-similar to those employed in professional sports (earned outcomes [EO] and wins above average [WAA])-to evaluate center-level performance in both surgical and endovascular treatment of CLTI. We hypothesized that high performance in both modalities conferred the best overall outcomes among centers. METHODS: Participating BEST-CLI centers were evaluated by composite major adverse limb events (MALE) or death, for all patients treated at a given site (bypass and endovascular, all BEST-CLI cohorts). WAA was calculated as a risk-adjusted, volume-sensitive measure derived from MALE/death using EO methods. Risk adjustment accounted for patient-level differences using a Cox proportional hazards model, excluding patients with incomplete data. Centers were ranked and divided into WAA quartiles from bottom (Q1) to top (Q4). Patient-level demographics and outcomes were compared across quartiles. Centers were further categorized based on WAA performance: above average (WAA >0) or below average (WAA <0) in bypass, endovascular therapy, or both. RESULTS: Analyses included 1440 patients (79% of randomized patients) across 146 centers. At 2 years, unadjusted MALE/death rates varied significantly by quartile (bottom Q1, 58%; Q2, 43%; Q3, 33%; top Q4: 30%; P < .001). Centers were evenly distributed based on WAA: both modalities above average (27%), bypass above average only (27%), endovascular above average only (21%), and both below average (25%). Among top centers (Q4), 84% achieved above average outcomes in both modalities, whereas 62% of bottom centers (Q1) were below average in both. Centers excelling in only one modality constituted 16% of top centers (3% bypass above average only, 14% endovascular above average only) and 38% of bottom centers (27% bypass above average only, 11% endovascular above average only). CONCLUSIONS: MALE/death varied considerably among BEST-CLI centers, with a difference of approximately 30% seen at 2 years between the bottom and top quartiles. Top performing centers consistently achieved above-average outcomes in both bypass and endovascular treatment. Conversely, centers exceling in only one modality were less likely to be top performers. These findings suggest that optimal CLTI care demands proficiency in both bypass and endovascular treatment and highlights the need for quality metrics that better differentiate center-level performance.
引用
- Jones DW, Powell RJ, Scali ST, et al. High-quality chronic limb-threatening ischemia care requires above average performance in surgical bypass and endovascular treatment. J Vasc Surg. 2026. PMID: 41644018. doi:10.1016/j.jvs.2026.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。